EARLY ANTIBODY THERAPY CAN INDUCE LONG LASTING IMMUNITY TO SHIV

Highly potent and broadly neutralizing anti-HIV-1 antibodies (bNAbs) have been used to prevent and treat lentivirus infections in humanized mice, macaques and humans(1–12). To determine whether the administration of combination bNAbs during the acute SHIV infection of rhesus macaques might lead to l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nature
Egile Nagusiak: Nishimura, Yoshiaki, Gautam, Rajeev, Chun, Tae-Wook, Sadjadpour, Reza, Foulds, Kathryn E., Shingai, Masashi, Klein, Florian, Gazumyan, Anna, Golijanin, Jovana, Donaldson, Mitzi, Donau, Olivia K., Plishka, Ronald J., Buckler-White, Alicia, Seaman, Michael S., Lifson, Jeffrey D., Koup, Richard A., Fauci, Anthony S., Nussenzweig, Michel C., Martin, Malcolm A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458531/
https://ncbi.nlm.nih.gov/pubmed/28289286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature21435
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak